派林生物

- 000403

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
派林生物(000403) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入43,564.07232,872.33137,481.3370,907.1826,086.03
营业收入43,564.07232,872.33137,481.3370,907.1826,086.03
二、营业总成本29,748.55163,949.55103,326.9857,234.9321,830.96
营业成本21,163.94112,987.8468,674.2636,341.5913,457.73
营业税金及附加453.882,169.061,171.14663.06281.30
销售费用3,395.6528,556.7020,225.7212,101.344,143.35
管理费用3,994.3518,024.6112,164.808,130.763,886.26
财务费用-1,345.73-5,757.18-4,285.08-2,939.28-1,365.12
研发费用2,086.467,968.515,376.142,937.451,427.44
资产减值损失----------
公允价值变动收益-423.86-1,896.97894.73565.60273.55
投资收益864.58740.21435.72259.3861.67
其中:对联营企业和合营企业的投资收益----------
汇兑收益----------
三、营业利润14,911.4069,518.7637,263.5616,136.356,317.35
加:营业外收入10.79353.17328.34107.510.02
减:营业外支出827.221,061.05585.00310.9325.68
其中:非流动资产处置损失----------
四、利润总额14,094.9768,810.8837,006.9015,932.936,291.69
减:所得税费用1,907.997,663.644,425.571,632.83669.86
五、净利润12,186.9861,147.2532,581.3314,300.105,621.83
归属于母公司所有者的净利润12,194.8661,211.1032,619.5414,313.725,637.61
少数股东损益-7.89-63.86-38.21-13.62-15.78
六、每股收益
基本每股收益(元/股)0.16690.83840.44600.19580.0771
稀释每股收益(元/股)0.16690.83840.44600.19580.0771
七、其他综合收益0.101.102.102.56-0.91
八、综合收益总额12,187.0861,148.3532,583.4314,302.665,620.92
归属于母公司所有者的综合收益总额12,194.9661,212.2132,621.6414,316.275,636.69
归属于少数股东的综合收益总额-7.89-63.86-38.21-13.62-15.78
下载全部历史数据到excel中 返回页顶